Article Versions Notes

Teran-Saavedra NG, Sarabia-Sainz JA-i, Silva-Campa E, Burgara-Estrella AJ, Guzmán-Partida AM, Ramos-Clamont Montfort G, Pedroza-Montero M, Vazquez-Moreno L. Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma. Molecules. 2019; 24(7):1382. https://doi.org/10.3390/molecules24071382

Teran-Saavedra, Nayelli Guadalupe, Jose Andre-i Sarabia-Sainz, Erika Silva-Campa, Alexel J. Burgara-Estrella, Ana María Guzmán-Partida, Gabriela Ramos-Clamont Montfort, Martín Pedroza-Montero, and Luz Vazquez-Moreno. 2019. "Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma" Molecules 24, no. 7: 1382. https://doi.org/10.3390/molecules24071382

Teran-Saavedra, N. G., Sarabia-Sainz, J. A.-i., Silva-Campa, E., Burgara-Estrella, A. J., Guzmán-Partida, A. M., Ramos-Clamont Montfort, G., Pedroza-Montero, M., & Vazquez-Moreno, L. (2019). Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma. Molecules, 24(7), 1382. https://doi.org/10.3390/molecules24071382